Cargando…

Colon Cancer Treatment Costs for Medicare and Dually Eligible Beneficiaries

To estimate the cost attributable to colon cancer treatment 1 year after diagnosis by cancer stage, comorbidity, treatment regimen, and Medicaid eligibility, we extracted an inception cohort of colon cancer patients aged 66 and older diagnosed between 1997 and 2000 from the Michigan Tumor Registry P...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Zhehui, Bradley, Cathy J., Dahman, Bassam A., Gardiner, Joseph C.
Formato: Texto
Lenguaje:English
Publicado: CENTERS for MEDICARE & MEDICAID SERVICES 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2832226/
https://www.ncbi.nlm.nih.gov/pubmed/20191756
_version_ 1782178316875202560
author Luo, Zhehui
Bradley, Cathy J.
Dahman, Bassam A.
Gardiner, Joseph C.
author_facet Luo, Zhehui
Bradley, Cathy J.
Dahman, Bassam A.
Gardiner, Joseph C.
author_sort Luo, Zhehui
collection PubMed
description To estimate the cost attributable to colon cancer treatment 1 year after diagnosis by cancer stage, comorbidity, treatment regimen, and Medicaid eligibility, we extracted an inception cohort of colon cancer patients aged 66 and older diagnosed between 1997 and 2000 from the Michigan Tumor Registry Patients were matched to non-cancer control subjects in the Medicare Denominator file. We used the difference-indifferences method to estimate costs attributable to cancer, controlling for costs prior to diagnosis. The mean total colon cancer cost per Medicare patient was $29,196. The method can be applied to longitudinal data to estimate long term costs of cancer from inception where incident patients are identified from a tumor registry.
format Text
id pubmed-2832226
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher CENTERS for MEDICARE & MEDICAID SERVICES
record_format MEDLINE/PubMed
spelling pubmed-28322262011-10-01 Colon Cancer Treatment Costs for Medicare and Dually Eligible Beneficiaries Luo, Zhehui Bradley, Cathy J. Dahman, Bassam A. Gardiner, Joseph C. Health Care Financ Rev Research Article To estimate the cost attributable to colon cancer treatment 1 year after diagnosis by cancer stage, comorbidity, treatment regimen, and Medicaid eligibility, we extracted an inception cohort of colon cancer patients aged 66 and older diagnosed between 1997 and 2000 from the Michigan Tumor Registry Patients were matched to non-cancer control subjects in the Medicare Denominator file. We used the difference-indifferences method to estimate costs attributable to cancer, controlling for costs prior to diagnosis. The mean total colon cancer cost per Medicare patient was $29,196. The method can be applied to longitudinal data to estimate long term costs of cancer from inception where incident patients are identified from a tumor registry. CENTERS for MEDICARE & MEDICAID SERVICES 2009 /pmc/articles/PMC2832226/ /pubmed/20191756 Text en
spellingShingle Research Article
Luo, Zhehui
Bradley, Cathy J.
Dahman, Bassam A.
Gardiner, Joseph C.
Colon Cancer Treatment Costs for Medicare and Dually Eligible Beneficiaries
title Colon Cancer Treatment Costs for Medicare and Dually Eligible Beneficiaries
title_full Colon Cancer Treatment Costs for Medicare and Dually Eligible Beneficiaries
title_fullStr Colon Cancer Treatment Costs for Medicare and Dually Eligible Beneficiaries
title_full_unstemmed Colon Cancer Treatment Costs for Medicare and Dually Eligible Beneficiaries
title_short Colon Cancer Treatment Costs for Medicare and Dually Eligible Beneficiaries
title_sort colon cancer treatment costs for medicare and dually eligible beneficiaries
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2832226/
https://www.ncbi.nlm.nih.gov/pubmed/20191756
work_keys_str_mv AT luozhehui coloncancertreatmentcostsformedicareandduallyeligiblebeneficiaries
AT bradleycathyj coloncancertreatmentcostsformedicareandduallyeligiblebeneficiaries
AT dahmanbassama coloncancertreatmentcostsformedicareandduallyeligiblebeneficiaries
AT gardinerjosephc coloncancertreatmentcostsformedicareandduallyeligiblebeneficiaries